Your support fuels our research to #EndALS! Donate Now

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Wednesday, May 11, 2022
Efficacy vs. Dose-Finding and Biomarker Validation: Two Kinds of Phase 2 Trials
Each clinical trial phase serves a particular purpose, although there is some variability and overlap in goals.
read more
Thursday, May 5, 2022
The Multistep Hypothesis: Ammar Al-Chalabi Explains Why Some Scientists Believe Six “Steps” Lead to ALS
Scientists don’t know what causes Amyotrophic Lateral Sclerosis (ALS). But many do believe, with relative certainty, that there are six biological “steps” that must occur in order for the onset of the disease to occur.
read more
Thursday, April 21, 2022
What Clinical Trials are Recruiting Right Now?
A list of phase 3 clinical trials recruiting in the United States as of April 2022.
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Tuesday, May 17, 2022
Luckiest Man on Earth by PT Muldoon
Our friend PT Muldoon wrote a poem to honor Lou Gehrig this Lou Gehrig Day.
read more
Thursday, May 5, 2022
Charlie Hargett: Remembering his Mother by Raising Money for Research
When ALS first came into Charlie’s life, he barely had time to wrap his head around what it was before it took his mother, Debra Jean Hargett, from him.
read more
Thursday, April 21, 2022
What Clinical Trials are Recruiting Right Now?
A list of phase 3 clinical trials recruiting in the United States as of April 2022.
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Tuesday, March 1, 2022
Tegoprubart: AT-1501’s New Name
AT-1501, a drug invented at the ALS Therapy Development Institute (ALS TDI) and being developed by Eledon Pharmaceuticals, has a new name: tegoprubart.
read more
Monday, January 31, 2022
ALS TDI and Google Develop New ALS Symptom Severity Measurement Tool
In a recently released preprint paper and accompanying GitHub link, ALS TDI and Google researchers share two AI-powered algorithms for more objectively measuring ALS disease symptom severity and progression.
read more
Tuesday, June 1, 2021
ALS TDI Launches New Young Faces of ALS Program
Young Faces of ALS Program spreads awareness about the impact that ALS can have on younger people; launch coincides with MLB's inaugural Lou Gehrig Day.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.